Dissertation > Excellent graduate degree dissertation topics show

Study of Drug-Eluting Stents in Treatment of Unprotected Left Main Coronary Artery Disease

Author: ZhuHaiJun
Tutor: CuiLianQun
School: Shandong University
Course: Internal Medicine
Keywords: Coronary atherosclerotic heart disease Percutaneous coronary intervention in patients Unprotected left main coronary artery disease Drug-eluting stents Syntax Credits
CLC: R541.4
Type: Master's thesis
Year: 2011
Downloads: 23
Quote: 0
Read: Download Dissertation

Abstract


Objective: To observe and analyze drug-eluting stent treatment efficacy and safety of unprotected left main coronary artery disease; observed unprotected left main coronary artery disease patients after interventional treatment of all-cause death, myocardial infarction, cerebrovascular events, target vessel revascularization the occurrence of major adverse cardiac and cerebral vascular events; prognosis of patients with different lesion characteristics, as well as different stent technology's impact on the prognosis. Subjects and methods: The study subjects from July 2004 to December 2009, the Shandong Provincial Hospital, Department of Cardiology line drug eluting stents (DES) treatment in patients with unprotected left main coronary artery disease (ULMCAD). Collect collate clinical data, including the general condition of the patients, coronary heart disease risk factors, laboratory biochemical markers, ECG, and echocardiography examination. Whether multivessel disease involving the left anterior descending artery, the circumflex artery or right coronary artery divided into groups (left main disease merger of two or three-vessel disease) according to coronary artery disease and non-vessel disease group (single branch isolated left main disease or merger vascular disease); patients with left main lesion is divided into non-bifurcation lesions and bifurcation lesions; bifurcation lesions group the different interventional surgical divided into single stent subgroup and double stent technology subgroups. The and application Syntax integral method for risk stratification (Syntax integral lt; 33 is divided into low and medium-risk group, Syntax Credits ≥ 33 minutes of high-risk groups). The patients were followed up regularly to track the occurrence of all-cause death, myocardial infarction, cerebrovascular events, target vessel revascularization, major adverse cardiac and cerebrovascular events (MACCE). The compare different lesions characteristic group and the different interventional surgical group clinical data and MACCE incidence differences. Results: Total elected to the 76 patients, age 40-78 (61.6 ± 9.5) years old, male 52 cases (68.4%). Hypertension, 45 cases (59.2%), diabetes mellitus in 14 patients (18.4%), dyslipidemia in 47 cases (61.8%), long-term heavy smokers of 37 cases (48.7%), obesity in 15 cases (19.7%), family history of CAD in 9 patients (11.8%). 2. Coronary angiography showed non multivessel disease group of 36 patients, the group of 40 patients with multivessel disease. Non-bifurcation lesions in 14 cases, 62 cases of bifurcation lesions. Use in bifurcation lesions the the single stent technology 29 cases; 33 cases of double stent technology, including nine cases of Crush Technique Mini-crush technology 18 cases, T stent technology 4 cases, 2 cases of modified T stent technology. Placed a total of 216 drug-eluting stents, surgical success rate of 100%. During hospitalization without MACCE occurred. Follow-up 12-78 (34.9 ± 16.6) months, all-cause death in 3 cases, myocardial infarction, 4 cases; 29 patients underwent coronary angiography, restenosis eight cases, which again line PCI 7 cases, coronary artery bypass grafting surgery (CABG) 1 cases. 1 year MACCE10 cases (13.2%) were followed up the endpoint total MACCE15 patients (19.7%). Non multivessel disease group compared with multivessel disease was no significant difference in the incidence of 1-year MACCE (5.6% vs 20.0%, P gt; 0.05); follow-up endpoint total MACCE incidence of multivessel disease group was significantly higher than the non- multivessel disease group (30.0% vs 8.3%, P lt; 0.05). The group of non-bifurcation lesions and bifurcation lesions compared with 1-year of MACCE and follow-up endpoint total MACCE occurrence rate was no significant difference (0.0% vs. 16.1%; 7.1% vs 22.6%, P are gt; 0.05). Bifurcation lesions in single stent technology subgroup 1 year of MACCE and follow-up endpoint total MACCE incidence was significantly lower than the double stent subgroup (3.4% vs. 27.3%; 10.3% vs 33.3%, JP, lt; 0.05). MACCE incidence difference between Syntax integral high-risk group and the low-risk group in 1 year was not statistically significant (27.8% vs 8.6%, P gt; 0.05); in the the MACCE incidence of high-risk end of follow-up group was significantly higher than the low-risk group (44.4% vs 12.1%, P lt; 0.05). COX regression analysis showed that The Syntax score ≥ 33 ULMCAD stenting in patients with MACCE independent predictive factors. Conclusion: drug-eluting stents for unprotected left main coronary artery disease have better short-term and long-term efficacy; merge in patients with multivessel disease and bifurcation lesions in patients with poor prognosis, especially line double stent-treated patients; Target vessel revascularization reconstruction is the most important adverse events after stenting; Syntax score ≥ 33 is an independent predictor of protected left main disease patients after stenting major adverse cardiac and cerebrovascular events.

Related Dissertations

  1. CHD patients with depression nitric oxide synthase gene G894T polymorphism,R749.4
  2. The Influence of Quality of Life on the Patients with Home Health Nursing Intervention,R473.2
  3. Analysis on the Relation of Atherosclerosis Interrelated Disease and Aortic Pulse Wave Velocity,R543
  4. Coronary angiography in patients with coronary heart disease TCM Characteristics,R259
  5. A Meta-Analysis of the Effect of Nicorandil on the Prognosis of Coronary Heart Diseases,R541.4
  6. Clinical Analysis of Surgical Ventricular Aneurysm Restoration for Left Ventricular Aneurysm Combined with Coronary Artery Bypass Grafting,R654.2
  7. The Technical Feasibility Analysis and Main Process Design of Drug-Eluting Stent Industrial Production,TH789
  8. The Relationship between Serum Soluble CD40 Ligand and the Plasma Soluble ICAM-1 and E-selectin Concentration in Patients with Acute Coronary Syndrome,R541.4
  9. Clinical Study of Heart Function Effect in AMI Patients with DES and Tirofiban,R542.22
  10. Study on Correlation between Apoliprotein E (ApoE) Gene and Lipoprotein Lipase(LPL) Gene Polymorphisms with Coronary Heart Disease (CHD) and Serum Lipids.,R541.4
  11. The clinical studies of percutaneous coronary angiography in patients with coronary heart disease TCM syndrome characteristics,R259
  12. Clinical Observation on Treating Coronary Atherosclerotic Heart Disease by Decoction of Yi Qi Tong Luo,R259.4
  13. Acupuncture at Neiguan NO, cGMP content in the plasma of patients with angina pectoris,R246
  14. MEF2A gene and ALOX5 gene polymorphism and coronary atherosclerotic heart disease,R541.4
  15. Study of Restenosis after Coronary Artery Intervention and Relevance Cell Factor,R541.4
  16. Plasma Homocyseteine Levels and the Left Ventricular Systolic Function in Diabetes Patients with Coronary Atheroslerotic Heart Disease,R587.2
  17. Study of In-vitro Degradation Behaviors of Poly (Lactide-co-glycolide) Films and Coatings,R318.08
  18. Drug-Eluting Stent in Coronary Artery Disease:a Meta-analysis,R541.4
  19. The Analysis on Affective Factor of in-stent Restenosis after Stent Implanted in Coronary Artery,R541.4
  20. A Study on the Change of the proANP in Patients with Acute Myocardial Infarction,R542.22

CLC: > Medicine, health > Internal Medicine > Heart, blood vessels ( circulatory ) disease > Heart disease > Coronary arteries ( atherosclerosis ),heart disease (CHD)
© 2012 www.DissertationTopic.Net  Mobile